If you or someone you know is battling Ovarian Clear Cell Carcinoma, discover how Dostarlimab can be an effective treatment option
To learn more about the clinical trial, including eligibility requirements and participating centers, please visit clinicaltrials.gov and enter ID NCT06065462
